Connect with us
DAPA Banner

Business

Restaurants add protein, fiber for weight loss drug users

Published

on

Restaurants add protein, fiber for weight loss drug users

A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized combo on Dec. 8, 2025 in New York City. Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are now popular for weight loss, according to a November poll by the non-profit health policy tracker KFF. Some in the restaurant industry are taking note.

Angela Weiss | AFP | Getty Images

The cost of GLP-1 drugs is falling, and pill versions are hitting the U.S. market. For restaurant chains and snacking giants, higher adoption of weight loss and diabetes treatments poses a threat to their sales — or an opportunity.

Advertisement

GLP-1 drugs slow digestion, suppress users’ appetites and increase satiety. For many restaurants and packaged food manufacturers, those reactions will likely mean weaker sales. Adults who use GLP-1s consume 21% fewer calories and spend nearly a third less on grocery bills on average, according to KPMG. JPMorgan estimates the growing use of the medications could wipe out $30 billion to $55 billion in annual sales for the food and beverage industry as soon as 2030.

About one in every eight U.S. adults is currently taking a GLP-1 drug like Ozempic or Zepbound, according to the KFF Health Tracking Poll conducted from Oct. 27 to Nov. 2. That number doesn’t include consumers who have discontinued their use of the drugs; 18% of respondents said that they have taken a GLP-1 medication at some point.

Those numbers are expected to keep climbing, especially after Novo Nordisk launched its Wegovy pill in January and Eli Lilly prepares to roll out its own oral drug this year. By 2030, more than 30 million Americans could be on a GLP-1 treatment, up from 10 million in 2026, based on J.P. Morgan estimates.

Michael Siluk | UCG | Universal Images Group | Getty Images

Advertisement

But the shift also presents an opportunity for restaurants and food and beverage companies.

With new protein- and fiber-rich options, many businesses are hoping to win over GLP-1 consumers and mollify investors’ concerns about how the treatments will affect their bottom lines.

“Whether it is labeling as GLP-1 friendly, decreasing the serving size, emphasizing protein content, or even when you shift over to the beverage world, because hydration is certainly a concern, there are a number of players that are starting to react to this,” said Don K. Johnson, principal of strategy and execution for EY-Parthenon.

Skipping snacks and breakfast

About half of GLP-1 users report consuming fewer calories while taking the medications, according to UBS Evidence Lab. But the effects aren’t even across the industry, and “certain categories are more impacted than others,” Johnson said.

Advertisement

Snacking, once one of the fastest-growing grocery segments, has taken the biggest hit. About 70% of GLP-1 users who report consuming fewer calories said that they are snacking less, according to a survey conducted by EY-Parthenon last spring.

“I think it is about the specific type of snack, but I do think they’re also snacking less … Having said that, we do see that there is a shift to healthier foods, and that certainly will include healthier snacking,” Johnson said.

Think more yogurt, nuts or fruit, and fewer chips or pretzels.

Since GLP-1 drugs lead patients to lower their caloric intake, every calorie consumed means more. Protein intake is more important to prevent muscle loss. So, too, is fiber to support gut health and digestion. And staying hydrated helps mitigate some of the drugs’ side effects, like nausea and headaches.

Advertisement

The effects of eating less extend to restaurants. About 60% of those respondents to the EY-Parthenon survey said that they are dining out less frequently.

The shift could also hit full-service restaurants where diners order a drink with their meals. Roughly 45% of survey respondents who are eating and drinking less said that they are drinking less alcohol.

Surveys conducted by Bernstein indicate that the frequency of restaurant visits among GLP-1 users can fall by as much as 45%, depending on the category of food and the nature of the occasion, analyst Danilo Gargiulo of Bernstein wrote in a research note published on Tuesday.

The pullback in restaurant visits isn’t spread evenly across times of day, according to Dana Baggett, executive director of restaurant client strategy at RRD, which works with more than 200 restaurant brands.

Advertisement

Lunch, so far, hasn’t been impacted, she said. But breakfast has taken a hit, particularly from high-income GLP-1 users, who represent a bigger percentage of current patients, she said. In practice, that means fewer sugary coffee drinks and doughnuts, although options like Starbucks‘ protein cold foam could encourage those consumers to return.

A commercial for GLP-1 drugs during the Super Bowl LX broadcast on television screens at a bar in Los Angeles, California, US, on Sunday, Feb. 8, 2026.

Jill Connelly | Bloomberg | Getty Images

Dinner, especially at fast-food restaurants, has taken the brunt of the damage so far.

Advertisement

Dinner traffic has fallen 6% among consumers who have been taking the medication regularly, according to Baggett; in other words, overall restaurant sales during dinner hours have declined about 0.4% due to GLP-1 use, she said. But as the number of consumers who use the drug consistently grows, so too will the pressure on restaurant traffic.

And snacking isn’t confined to grocery store aisles. For limited-service restaurants, like McDonald’s or Taco Bell, snacking accounts for 12% of spending, according to Bank of America Global Research.

Even so, threats to those large restaurants chains may only be gradual, which gives them time to adapt.

“I think there shouldn’t be this panic out there in the marketplace, but this is a trend that’s not going away,” Baggett said. “This is an amazing opportunity for brands to start repositioning themselves and focusing on what consumers want: less sugar, higher protein and that focus on fiber.”

Advertisement

How Big Food is evolving

If recent earnings conference calls are any example, restaurant and food executives also think that it isn’t time to panic just yet. For some companies, the trend offers a chance to reach new customers through healthier options.

“I think there are more opportunities than threats, but there are both,” PepsiCo CEO Ramon Laguarta told Wall Street analysts on the company’s earnings conference call in early February.

In recent months, Pepsi has released protein-packed Doritos, relaunched Gatorade and unveiled fiber-rich varieties of SunChips and Smartfood popcorn. Those moves are part of the company’s broader strategy to modernize its portfolio and boost sales by appealing to health-conscious consumers, but they also align with Laguarta’s assumption that GLP-1 medications will be adopted more broadly.

Domino’s Pizza CEO Russell Weiner sounded unshaken when he told analysts last month that the pizza chain hasn’t seen GLP-1 drugs affect its sales yet.

Advertisement

“Dinner, for us, is a sharing occasion, so perhaps that’s why we’re not seeing any impact, but we’re going to continue to watch it,” he said. “But if there needs to be menu innovation around that, we will do that.”

RRD’s Baggett told CNBC that she thinks portions and snack sizing will be key for restaurants to attract consumers who are on GLP-1 treatments.

When asked about the drugs on McDonald’s earnings conference call last month, CEO Chris Kempczinski touted the burger chain’s existing protein options. But he added that the preferences of GLP-1 users are also being considered as the chain creates new menu items.

“We’re also seeing changes around maybe less snacking, changes in some of the beverages that they drink, less sugary drinks, and so all of those things are factoring into some of what we’re out there experimenting with and testing with,” he said.

Advertisement

Other restaurant chains have already launched options that appeal to diners on GLP-1 drugs, even if the medications weren’t the key impetus. For example, Chipotle launched grab-and-go protein cups in December, aiming to cash in on the protein and snacking crazes as its restaurant sales struggled.

And Olive Garden, owned by Darden Restaurants, released a Lighter Portions menu last year, downsizing a handful of its classic entrees at a lower price. Darden CEO Rick Cardenas said that the chain introduced the new menu to give all of its customers more options.

“It just so happens to benefit the consumers that might want smaller portions that are on GLP-1 medications, and we have a lot of options like that in all of our menus,” Cardenas said on the company’s earnings conference call in December.

Marketing to GLP-1 users

Other companies have explicitly appealed to GLP-1 users, particularly when it comes to innovation.

Advertisement

In 2024, Nestle led the pack when it launched Virtual Pursuit, a frozen-food brand targeting GLP-1 users. While the packaging initially didn’t call out that it was “GLP-1 friendly,” the food company updated it later to include it prominently, boosting sales.

“It’s a big initiative for Nestle,” Nestle USA CEO Marty Thompson told CNBC at a media event earlier in March. “There will be those things that are designed for GLP-1, and there will be those things that will be sort of a companion to GLP-1, clearly calling out protein and fiber, but not necessarily designed portion-size wise or whatever for GLP-1.”

Nestle’s focus will extend beyond food, too. Thompson said that the company plans to expand into beverages and listed protein shakes as one potential way to appeal to GLP-1 customers.

Even food companies without much exposure to GLP-1 users are broadening their portfolios to reach them.

Advertisement

Close-up view of Dippin’ Dots ice cream cup in a person’s hand, Santa Cruz, California, June 22, 2024.

Smith Collection | Gado | Archive Photos | Getty Images

For example, Dippin’ Dots and Icee owner J&J Snack Foods makes most of its sales in stadiums, theme parks and malls. Because of its “experiential” focus, CEO Dan Fachner told CNBC that he thinks that J&J is more insulated from the effect of GLP-1 drugs compared with its snacking peers.

“I still think that in most cases, even people on GLP-1 drugs will still use those occasions for snacking,” he said.

Advertisement

Even still, more than a year ago, Fachner presented employees with a challenge for the company’s grocery business, which accounts for 13.5% of annual sales.

“Take the core products — pretzels and churros and Icees and Dippin’ Dots and frozen novelties — tell me how we can make them more GLP-1 friendly as it continues to grow,” he said.

This year, J&J has a number of new products hitting the freezer aisle. Protein has been added to its soft pretzels, now available in a smaller portion size. And Luigi’s Italian Ice, traditionally sold in a cup, will come in a “mini pop size,” with a formula that includes more antioxidants or helps hydration, according to Fachner. If the new products succeed in grocery stores, then J&J plans to take them to the company’s food service customers, as well.

J&J’s new products also have the benefit of appealing to a wider audience than just consumers who are on GLP-1 medication. For example, Fachner expects the new Luigi’s mini pops will appeal to health-conscious moms as a snack for their kids.

Advertisement

Uptake could change strategies

For restaurants and food suppliers, current data on the eating and drinking habits of GLP-1 users are informing their efforts to appeal to those consumers. But that behavior can still fluctuate.

About 5% of users lapse in taking the medications, due to cost, side effects or hitting their weight goal. After quitting, they tend to maintain the same eating habits for a couple of months before eventually returning to a higher caloric intake.

“I think that we don’t spend enough time talking about the fact that there may be sort of a cycle of behaviors — people going on and off of the drugs — that will have sort of an interesting impact on manufacturers of food because there’s no ‘before’ and ‘after,’” EY’s Johnson said. “It’s a process.”

And a whole new group of consumers could soon be taking daily pill versions of GLP-1 medications. It’s too soon to tell if oral GLP-1 drugs will result in more consistent usage or higher quit rates and to know who exactly is trying the pill version over the injectable.

Advertisement

“I don’t have a crystal ball, but my guess is from our survey that the folks using the oral version of the drug will be a new set of people, because one of the barriers to trial was — as can be expected — a lot of people don’t like to take shots of injections,” Johnson said.

There is one prediction that is widely accepted: the pill version will mean much higher adoption of GLP-1 drugs.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Labor Secures Landslide Victory as One Nation Surges Past Liberals

Published

on

Zayed International Airport Abu Dhabi International Airport

ADELAIDE, Australia — South Australian Premier Peter Malinauskas led the Labor Party to a decisive second-term victory in the March 21, 2026, state election, expanding its majority in the House of Assembly amid a dramatic collapse of the Liberal opposition and a stunning surge by One Nation that reshaped the political landscape.

Peter Malinauskas
Peter Malinauskas

With counting ongoing late Saturday night, Labor was projected to secure at least 30 seats in the 47-member lower house — up from 27 before the election — while the Liberals appeared headed for a historic low of just four seats. Independents were on track to claim at least four, with preferences still flowing in key marginals. The result delivered Malinauskas a commanding mandate after a campaign dominated by cost-of-living pressures, housing affordability and immigration debates.

Labor captured nearly 38% of the primary vote, comfortably ahead of One Nation’s 21% and the Liberals’ dismal 19%. On a two-party-preferred basis, Labor held a commanding lead of around 59-41 against both major opponents, marking what analysts described as the party’s strongest performance in state history. The swing toward Labor reached 4-5% in many seats, fueled by strong urban and suburban turnout.

The outcome devastated the Liberal Party, led by Ashton Hurn, who assumed the leadership only in December 2025. The Liberals suffered their worst result since federation in any state or federal contest, with early concessions from Hurn at Morphettville Racecourse acknowledging defeat. The party hemorrhaged support in traditional strongholds, particularly outer metropolitan and regional areas where voters shifted to One Nation’s anti-establishment message.

One Nation, under Pauline Hanson’s national banner and with local candidates including Cory Bernardi in some contests, achieved its best-ever primary vote in South Australia. The party’s 21% primary share — up dramatically from just 2.6% in 2022 when it ran in fewer seats — reflected deep discontent with the major parties. Support was particularly strong in regional electorates and outer suburbs, where voters cited economic hardship, immigration concerns and distrust of elites. Despite the surge, One Nation appeared unlikely to win any lower-house seats due to preference flows favoring Labor or independents, though its vote split the conservative bloc and indirectly aided Labor’s gains.

Advertisement

Malinauskas declared victory shortly after 10 p.m. ACDT, thanking voters for endorsing his government’s record on jobs, health and infrastructure. “South Australians have spoken clearly: they want a government focused on delivery, not division,” he said in his victory speech. The premier highlighted achievements like hospital expansions, renewable energy projects and cost-of-living relief measures that resonated with working families.

The campaign featured unusual dynamics, with Malinauskas directly confronting Hanson’s anti-immigration rhetoric in debates and media appearances. Hanson responded sharply, accusing Labor of ignoring regional concerns. The exchange amplified One Nation’s visibility, contributing to its breakthrough performance.

Early voting turnout reached record levels, with more than 454,000 pre-poll ballots cast — a significant portion of the electorate — helping Labor build an insurmountable lead by election night. The South Australian Electoral Commission reported smooth polling day operations, with final results expected over coming days as postal and absentee votes are processed.

The election outcome carries national implications. Labor’s dominance in a traditionally competitive state bolsters federal prospects ahead of potential early polls, while the Liberals’ collapse raises questions about opposition strategy under federal leader Peter Dutton. One Nation’s rise signals growing populist sentiment, echoing trends in other states and potentially influencing Senate dynamics.

Advertisement

Malinauskas, who became premier in 2022 after ending 16 years of Liberal rule, now commands a strengthened majority to pursue ambitious reforms in housing, energy transition and economic diversification. Critics within the party and independents will watch closely for delivery on promises amid fiscal constraints.

As counting continues, the 2026 South Australian election will be remembered as a landslide for Labor, a humiliation for the Liberals and a watershed moment for One Nation’s breakthrough into mainstream contention.

Continue Reading

Business

Credo: The Market Got It Wrong (NASDAQ:CRDO)

Published

on

Data Center and Internet cables plugged in network server. Internet security network and safe data concept. Database storage. Cloud computing technology. 3d render

This article was written by

Hi, I’m Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. Investment Style: Spotting high-potential winners before they break out, focusing on asymmetric opportunities (with at least upside potential of 3-5X outweighing the downside risk). By leveraging market inefficiencies and contrarian insights, we seek to maximize long-term compounding while protecting against capital impairment.Risk management is paramount—we seek a strong margin of safety to protect against capital impairment while maximizing long-term compounding. Our 2-3 year investment horizon allows us to ride out volatility, ensuring that patience, discipline, and intelligent capital allocation drive outsized returns over time.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in CRDO over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Prestige Consumer Healthcare Inc. (PBH) Breathe Right – M&A Call – Slideshow

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Prestige Consumer Healthcare Inc. (PBH) Breathe Right – M&A Call – Slideshow

Continue Reading

Business

Sprout Social: Improving Fundamentals Pushing Stock Into Deep Value Zone; Reiterating Buy

Published

on

Sprout Social: Improving Fundamentals Pushing Stock Into Deep Value Zone; Reiterating Buy

This article was written by

I am a private, long-term individual investor with more than 10 years of experience in the equity markets. Over that time I have developed a fundamentally driven, value-oriented approach with a particular interest in companies that are either undervalued or at an inflection point where a turnaround is possible. I spend most of my time looking for situations where market sentiment is overly pessimistic relative to a company’s underlying fundamentals and long-term prospects. For example i initiated positions shortly before meaningful positive re-ratings and fundamental turnarounds for JAMF and Unity Software. I am not a professional fund manager and do not work in the financial industry; I write purely from the perspective of an engaged, research-driven retail shareholder. My educational and professional background is outside of formal finance, which I see as an advantage: it forces me to explain my theses in clear, practical language instead of relying on jargon. My motivation for writing on Seeking Alpha is to share my investment theses, stress-test my ideas with a broader audience and contribute to a serious, data-driven discussion around businesses I follow closely. I hope my work can be useful to other investors who are interested in deep dives on valuation. The views I express are my own as an individual shareholder and do not constitute investment advice.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SPT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

(VIDEO) BTS Comeback Concert Draws 40,000 Fans to Gwanghwamun Square in Emotional Seoul Return

Published

on

BTS Comeback Concert Draws 40,000 Fans to Gwanghwamun Square in

SEOUL — BTS performed their first full-group concert in nearly four years Saturday, March 21, 2026, at Gwanghwamun Square in central Seoul, drawing an estimated 40,000 to 42,000 fans to the historic plaza despite initial expectations of up to 260,000 attendees.

BTS Comeback Concert Draws 40,000 Fans to Gwanghwamun Square in
BTS Comeback Concert Draws 40,000 Fans to Gwanghwamun Square in Emotional Seoul Return

The one-hour free event, titled “BTS THE COMEBACK LIVE | ARIRANG,” marked the septet’s official return after completing mandatory military service and the release of their fifth studio album *Arirang* on March 20. The seven members — RM, Jin, SUGA, j-hope, Jimin, V and Jung Kook — delivered a set heavy on new material from the album, blending Korean cultural motifs with their signature sound in front of a sea of purple light sticks.

Seoul Metropolitan Government and police estimates placed attendance at 40,000-42,000 in the Gwanghwamun area as the show began at 8 p.m. KST, significantly below pre-event projections of 260,000 that prompted massive security preparations including 15,000 personnel, anti-drone systems and traffic restrictions. About 22,000 fans with free tickets accessed a cordoned-off standing area near the stage, while others watched from surrounding streets on temporary screens or via Netflix’s global livestream to 190 countries.

The lower turnout reflected stricter crowd controls and the symbolic yet compact venue choice — Gwanghwamun Square, flanked by Gyeongbokgung Palace and statues of King Sejong and Admiral Yi Sun-sin — rather than a larger stadium. Authorities designated the area “crowded” but managed dispersal smoothly, with Gwanghwamun Station resuming service by 10 p.m. as fans exited.

The concert opened with RM greeting the crowd: “Hello, Seoul,” before launching into tracks like “Body to Body” and “Swim,” the lead single. The setlist emphasized *Arirang*’s themes of Korean identity and resilience, with fan-favorite moments including group harmonies on “Into the Sun” and a medley nod to older hits. Jung Kook’s high notes, Jimin’s emotive delivery and SUGA’s rap intensity drew cheers, while the members appeared energized despite the long hiatus.

Advertisement

HYBE, BTS’s agency, described the event as a “historic milestone,” with the title *Arirang* — drawn from Korea’s beloved folk song — symbolizing roots and renewal. RM reflected on the wait: “We’ve been away, but our hearts never left.” The show also served as a prelude to the *Arirang World Tour*, starting April 9-12 in Goyang, South Korea, with 82 dates planned across continents through 2027.

The free, open-air format aimed to reach as many fans as possible, with Netflix handling the global stream. While physical attendance fell short of hype, the broadcast reached millions, reaffirming BTS’s worldwide influence. Fans chanted and danced safely, with police praising orderly behavior amid the massive gathering.

The event underscored K-pop’s cultural weight in Korea, temporarily transforming a political and historical landmark into a celebration space. Security was tight — body checks, barricades and restricted access — but the atmosphere remained festive, with purple lights illuminating the square long after the performance ended.

As BTS embarks on their next chapter, the Gwanghwamun show will be remembered as a heartfelt reunion blending intimacy with spectacle, even if the crowd size surprised some observers. The group’s return signals renewed momentum for K-pop’s biggest act.

Advertisement

Continue Reading

Business

Australian Shares Close Lower as ASX 200 Falls 0.82% to 8,428 on Mining Weakness

Published

on

ASX headquarters at 39 Martin Place, Sydney

SYDNEY — The Australian share market extended its recent losses Friday, March 20, 2026, with the benchmark S&P/ASX 200 index declining 69.4 points or 0.82% to close at 8,428.40 — its lowest finish in four months and marking a third straight weekly drop amid persistent Middle East tensions and commodity price pressure.

ASX headquarters at 39 Martin Place, Sydney
ASX headquarters at 39 Martin Place, Sydney

Trading volume reached around 2.39 billion shares, with the index ranging from a low of 8,427.20 to a high of 8,497.80 before settling lower. The broader All Ordinaries index fell 62.4 points or 0.72% to 8,628.30. Year-to-date in 2026, the ASX 200 is down 3.28%, though it remains 6.27% higher than a year ago.

The sell-off reflected ongoing fallout from the U.S.-Israeli conflict with Iran, now in its eighth week, which has driven oil prices higher while weighing on metals and broader growth-sensitive sectors. Brent crude remained elevated, supporting energy stocks but pressuring miners as iron ore, copper and aluminium prices softened.

The materials sector led declines, sliding 1.5% as mining giants faced heavy selling. BHP Group dropped 1.8%, Rio Tinto fell 2.9%, and gold miners retreated sharply with bullion under pressure from inflation fears tied to the conflict. The resources sub-index lost 1.15% for the day, contributing significantly to the index’s drop.

Banking stocks also weighed, ending 1.1% lower as the big four lenders traded in the red. Energy names provided a rare bright spot, rising 0.7% to their highest level since February 2024 on oil gains following Iranian attacks on regional energy infrastructure. European and Japanese support for Strait of Hormuz shipping security and U.S. supply-boost measures offered some offset, but the broader market tone stayed defensive.

Advertisement

The week’s performance was grim: the ASX 200 shed 2.19% over five days and about 7% (roughly $250 billion in market value) since the conflict escalated, according to ABC News and other reports. Thursday’s session had seen a modest rebound, but Friday’s weakness resumed the trend of volatility driven by geopolitical risks and commodity swings.

Broader influences included China’s low growth target and global rate uncertainty. Money markets have dialed up bets on potential rate rises as energy costs feed inflation, adding pressure on consumer and cyclical stocks. The Australian dollar traded around 71.8 US cents, up modestly but still reflecting caution.

Analysts noted the ASX 200’s breach of key support levels, including its 50-day moving average, as a technical signal for further downside risk if tensions persist. Energy stocks’ relative strength provided a hedge, but materials’ heavy weighting dragged the benchmark lower.

Looking ahead, investors will monitor oil developments, any de-escalation signals from the Middle East, and upcoming domestic data. With the index at a four-month low, bargain hunters may emerge on dips, though persistent inflation and geopolitical uncertainty could cap rebounds.

Advertisement

The close capped a turbulent week for Australian equities, with miners and banks bearing the brunt while energy offered limited relief. As global crosscurrents dominate, the ASX 200 remains vulnerable to further swings in commodity prices and risk sentiment.

Continue Reading

Business

Elon Musk offers to pay TSA salaries amid budget battle, airport lineups

Published

on

Elon Musk offers to pay TSA salaries amid budget battle, airport lineups


Elon Musk offers to pay TSA salaries amid budget battle, airport lineups

Continue Reading

Business

Trump threatens to deploy ICE agents to U.S. airports

Published

on


Trump threatens to deploy ICE agents to U.S. airports

Continue Reading

Business

Trump threatens to put ICE agents in airports over funding impasse

Published

on

Trump threatens to put ICE agents in airports over funding impasse


Trump threatens to put ICE agents in airports over funding impasse

Continue Reading

Business

Exclusive-Bahrain cites Patriot interception in March 9 Iranian drone incident

Published

on

Exclusive-Bahrain cites Patriot interception in March 9 Iranian drone incident


Exclusive-Bahrain cites Patriot interception in March 9 Iranian drone incident

Continue Reading

Trending

Copyright © 2025